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The purpose of this study was to determine the use of antibacterial drugs in Canadian dairy farms. The data collection for this report took place on 84 different dairy farms distributed over the Western Centre (Alberta), the Ontario Centre (Ontario), the Quebec Centre (Quebec), and the Atlantic Centre (New Brunswick, Nova Scotia and Prince Edward Island) during April till November 2007. During this period the dairy farms in Canada used 0.036 grams of active ingredient per cow per day. The use of antibacterial drugs in terms of the total amount and different antimicrobial drug classes, differed per farm and per centre. The average number of cows on a farm seems to have no influence on the use of antibiotics, in contrast to the different dairy barn types. Bedding- pack barns seem to use more antibiotics than tie-stall barns and free-stall barns. Looking at the classification of the veterinary antibiotics from human medicine importance aspect as determined by Health Canada, 55.49% of the antimicrobials used on farms are of high importance, because they are used to treat different human infections, including serious infections, and for which alternatives are generally available. The data published in this report contains useful information which may be helpful in decreasing the use of antibiotics in the future and it may also lead to safer and judicious use of antimicrobials in veterinary medicine, taking the human health into account. 

Introduction
The purpose of this study was to determine the use of antibacterial drugs in Canadian dairy farms. To determine this, it is important to get an answer on the following questions:
1.	What kind of antibacterial drugs are used and in what amount?
2.	How is the use of antibacterial drugs distributed amongst the different provinces in Canada?
3.	To what extent will factors such as the total number of cows on a farm or the barn type influence the use of antibacterial drugs?
4.	How important are the antibacterial drugs used in veterinary medicine to those used in human medicine?
This is the first study of its kind about the use of antibacterial drugs in Canada over a large area. Lack of previous results make comparisons not possible. In contrast with Canada, the use of antibiotics in dairy farms in the Netherlands is annually published in a Maran report. The use of antimicrobial drug classes in Canada and the Netherlands are compared with each other in this report. 

The data published in this report contains useful information which may be helpful in decreasing the use of antibiotics in dairy farms in the future. It may also lead to a safer and judicious use of antibacterial drugs in veterinary medicine, taking the human health into account. The development of resistance in both human and animal bacterial pathogens has been associated with the extensive (Normanno et al., 2007) and improper use (Moon et al., 2007) of antimicrobials over the years. Therapy of infectious diseases in animals poses the risk of selection of resistant strains and introduction of these strains into the food chain (Moon et al., 2007). Antimicrobial resistance is an important public health concern worldwide (Normanno et al., 2007). A very important and upcoming problem is the methicillin-resistant Staphylococcus aureus (MRSA).
Methicillin-resistant Staphylococcus aureus
Many of the S. aureus strains are resistant to penicillinase-resistant penicillins because of the long-term use of β-lactam antibiotics in agricultural and healthcare settings. When S. aureus is carrying a mecA gene that confers resistance to all ß-lactam drugs, it is referred to as methicillin (oxacillin)-resistant S. aureus (MRSA). Nowadays, S. aureus generally exhibits a multiple resistance to tetracyclines, aminoglycosides, macrolides, lincosamides and some other antimicrobial drugs and it has already become widespread. The rate of methicillin resistance among S. aureus is in Korea, by now, greater than 50% (Moon et al., 2007).

Staphylococcus aureus causes severe diseases in animals and humans. In animals it can cause diseases like mastitis, arthritis and urinary tract infections. In humans it is an important cause of food poisoning, pneumonia, postoperative wound infections and nosocomial infections (Lee, 2003). Nosocomial infections, also known as hospital acquired infections, are infections which are a result of treatment in a hospital or a healthcare service unit, but they are secondary to the patient’s original condition. They first appear 48 hours or more after hospital admission or within 30 days after discharge. The most common nosocomial infections are urinary tract infections and pneumonias (http://en.wikipedia. org). 
Each year, an estimated 1.7 million individuals acquire a nosocomial disease in the United States, resulting in nearly 100,000 deaths and this costs the hospitals an extra 6.5 billion dollars. Many of these infections are caused by antimicrobial-resistant pathogens. MRSA is one of the most prevalent pathogens causing nosocomial disease in hospitals worldwide (Diekema and Climo, 2008). MRSA infections in human beings were, until recently, mainly hospital acquired infections. Currently, the incidence of community-acquired MRSA infections in industrialized countries is increasing (Normanno et al., 2007). To control the spread of MRSA infections, sources of contamination and mechanisms of transmission must be identified (Lee, 2003).

Mastitis is the most common reason for antimicrobial drug use in dairy herds. Staphylococcus aureus is one of the most significant pathogens causing clinical and subclinical bovine mastitis worldwide. These infections respond poorly to antimicrobial drugs (Moon et al., 2007). The probability of cure of S. aureus depends on cow, pathogen and treatment factors. The cure rates decrease with:
-	increasing age of the cow
-	increasing somatic cell count (SCC)
-	increasing duration of infection
-	increasing bacterial colony counts in milk before treatment
-	increasing number of quarters infected
-	decreasing duration of treatment
Besides a higher cure rate, longer treatment also results in a decreasing SCC and a decreasing risk of transmission among the different quarters of a cow, and amongst different cows in a herd. Increasing the duration of treatment is not always economically feasible. The benefits must be weighed against the disadvantages, like the price of the antibiotics, the loss of milk due to withdrawal, the increased risk of residues in the milk, and the increasing risk of infecting a cow through infusions via the teat canal (Barkema et al., 2006).
The resistance of a significant proportion of S. aureus strains to antibiotics is one of the evident reasons for the poor response to treatment (Barkema et al., 2006). In Korea 2.5% of the S. aureus, isolated from bovine mastitic milk, were resistant to methicillin. This study also indicates that major epidemic MRSA clones may spread not only from cow to cow, but also between different dairy farms (Moon et al., 2007). 

Food borne acquired MRSA outbreaks have been reported. The source of food contamination with MRSA is still not completely clear. Normanno et al. (2007) found MRSA strains in bovine milk; two strains belonged to the ovine biovar and two were non-host-specific. This suggests that ruminants, besides humans, may act as reservoirs for MRSA strains. Although this study only found small amounts of MRSA in bovine milk, it can still cause (lethal) disease in especially immunocompromised human beings, because these persons have a decreased ability of preventing colonization of the gastrointestinal tract by the pathogens (Normanno et al., 2007).
The possibility of ruminants being a reservoir for MRSA strains, causing diseases in human beings, emphasizes the importance of safer drug use in veterinary medicine. The following process allows safer drug use and thereby contributes to an improvement in management and cure of S. aureus:
1.	Early detection of an infected quarter: this can be achieved by monthly screening of cow-level SCC, followed by identification of infected quarters using the California Mastitis Test (CMT) and culture of milk samples from quarters with positive CMT results.
2.	Rapid follow up on information from tests.
3.	Accessible cow-level data: data on parity, lactation stage, pregnancy status, production level and history of mastitis and SCC.
4.	Characterization of S. aureus isolates: it is important to know if an isolate is sensitive for penicillin or not, considering the possible resistance.
5.	A protocol for decision making on the choice and duration of treatment: taking cow, pathogen and treatment factors into account.
To reduce transmission of S. aureus among quarters and among cows in a herd, it is also important to use proper milking procedures, post-milking teat disinfectants, and separation or culling of chronically infected animals (Barkema et al., 2006).
The influence of barn design on cow health
Dairy cattle housing has a large impact on cow health. A study in Norway found more clinical mastitis, more ketosis, and a lower mean fertility index in herds with tie-stalls in comparison with herds in free-stalls (Valde et al., 1997). In Canada, Olde Riekerink et al. (2008) saw a higher incidence rate of clinical mastitis caused by S. aureus, Streptococcus uberis, and coagulase-negative staphylococci in cows in tie-stalls in comparison with those in free-stalls. In contrast, cows in free-stalls had a higher incidence rate of clinical mastitis caused by Klebsiella spp. and Escherichia coli than cows in tie-stall barns (Olde Riekerink et al., 2008). 
Cook (2003) found a significantly higher prevalence of lameness during the winter in free-stall herds in comparison with tie-stall herds, no significance was found during summer. Sogstad et al. (2004) saw more infectious and metabolic claw lesions in free-stalls than in tie-stalls, 71.8% versus 48% respectively. Claw disorders cause about 90% of lameness in dairy cattle. Lameness is considered to be among the three costliest diseases in dairy, after mastitis and fertility problems (Sogstad et al., 2004). These costs include those of antibiotics.
Materials and methods
Canadian Bovine Mastitis Research Network
This study is part of the Canadian Bovine Mastitis Research Network (CBMRN). Fourteen Master of Science students, fourteen PhD students and four post-docs are working within the CBMRN at this moment. Right now there are 10 research projects running at nine different Canadian universities and two research institutions. This research on the use of antimicrobial drugs on Canadian dairy farms is part of one of these research projects. The data collection of the CBMRN for this study started in February 2007.
The mission of the CBMRN is to mobilize national and international scientific and financial recourses to:
-	decrease the incidence of mastitis 
-	reduce financial losses according to mastitis 
-	maintain milk quality through concerted research 
-	maintain effective and rapid transfer of results to end-users

The CBMRN has four supervising centres, these four centres include:
1.	The Western Centre (Alberta). The data collection takes place at 17 dairy farms and this is coordinated by the University of Calgary.
2.	The Ontario Centre (Ontario). In this centre the University of Guelph is coordinating the data collection. Twenty-two dairy farms participate in this project in this centre.
3.	The Quebec Centre (Quebec). The Quebec centre contains 28 dairy farms for data collection and this is coordinated by the University of Montreal.
4.	The Atlantic Centre (New Brunswick, Nova Scotia and Prince Edward Island). The University of Prince Edward Island is coordinating the data collection, which takes place at 17 dairy farms.
The reason why the number of farms differs per centre is that the dairy population is concentrated in Quebec and Ontario. Most of the Canadian dairy farms, about 81%, are located in Quebec and Ontario, 13% of them are located in the Western Provinces and 6% are in the Atlantic Provinces (http://www.medvet.umontreal.ca (​http:​/​​/​www.medvet.umontreal.ca​)). To make the farms in the CBMRN more representative for the Canadian dairy situation, relatively more farms were selected from these two provinces (Quebec and Ontario). Additionally, a small number of farms dropped out of the project after the selection.


Figure 1 shows the map of Canada (http://editie1.terra.wolters.nl). The white dots are the places with coordinating functions. Data collection take place near these dots to reduce the travel time of the CBMRN staff and therefore improving the efficiency of the research.


Figure 1. Map of Canada: 1. Western Centre, 2. Ontario Centre, 3. Quebec Centre, and 4. Atlantic Centre. The white dots are the locations of the universities with coordinating functions within the CBMRN. (http://editie1.terra.wolters.nl)

The dairy farms which are selected for the data collection for the CBMRN are selected by the following criteria:




-	New Brunswick, PEI, Nova Scotia: 48%
	The selected herds have to be a reflection of the rest of the herds in a province.
2.	Bulk Tank SCC (BTSCC):  The herds are divided in three different BTSCC groups, based on the most recent 12-month period, these three different BTSCC groups are:
-	≤ 150 000 cells/ml
-	> 150 000 cells/ml and ≤ 300.000 cells/ml
-	> 300 000 cells/ml
	Each group has to have an equal number of selected herds. The BTSCC are 	obtained from candidate dairy farms or their veterinarians. 
3.	Breed: Herds with less than 80% (or less than 15) Holstein Friesian lactating and dry cows at the moment of selection, are excluded from participation in the research project. Non-Holstein Friesian cows are allowed to be sampled for clinical mastitis, but they will not be included in the dry cow/fresh cow portion of the study, nor in any intensive sampling.
4.	Milking schedule: Herds following a three times milking schedule are excluded from participation in the research project.
5.	Dairy Herd Improvement (DHI): All herds must be participating in data collection trough DHI in their region.
These selection criteria are based on different research projects, including the mastitis project and the antibiotics project. During a visit to a selected farm, data for different projects are collected (National Cohort Reference Manual, CBMRN).
Data collection
Every participating farmer has a garbage bin with the words: “all drugs” to put all the used drugs in. Once a month the drugs are counted by the CBMRN staff. They write down the names of the drugs and tally the drugs used on the drug tally sheets provided for this purpose. The University of Calgary (Western Centre) assembles the data of all four centres. 
Data conversion
Of every drug used on a farm the amount of it is written down. The noted amount is converted to the quantity of active ingredient of the drug per cow per day. This conversion is essential to make the comparison of the used amount of antibiotics reliable among the different farms. The quantity of active ingredient per volume can be found on the packaging of a drug. A list of the number of cows per month on a farm is kept by the CBMRN staff itself, this list includes the months April, May, June, July, August, September, October, November and December of 2007. The number of cows in February and March of 2007 are not yet available. The quantity of antibiotics used on a farm in these months, is divided by the number of cows in April of that particular farm. 
Categorization of antimicrobial drugs based on importance in human medicine
Antimicrobial drugs are used in human and veterinary medicine primarily for the treatment, control and prevention of bacterial diseases. In the agri-food industry some of these drugs are used for growth promotion and improvement of feed efficiency. Many of the chemical classes of antimicrobial drugs used in humans are also used in animals, even those which are essential for the treatment of serious life-threatening infections. Some of these drugs may become ineffective, because of the development of antimicrobial resistance. Alternative antimicrobials may not be available to treat infections caused by resistant bacteria. Therefore, it is very important to develop measures to reduce the loss of effectiveness of drugs, especially life-saving drugs.

Health Canada has tried to categorize antimicrobial drugs according to their importance in the treatment of serious bacterial infections. Resistance development against the more important drugs in this categorization might have more serious consequences in human health. This drug categorization is expected to assist the regulatory risk assessment process during pre- and post-market evaluation of veterinary antimicrobials. 

The categorization focuses on the antibacterial drugs. Other antimicrobials, for example antifungal or antiviral drugs, are less frequently used in animals and therefore excluded. To make this categorization, the antibacterial drugs have been ranked according to their chemical class. Each class has been placed in a category where the majority of the drugs within the class may fall. Some of the drugs within a class may not fall in the same category as the rest of the class and these exceptions will be treated on a case-by-case basis. Another point which is important to take into account is the fact that the importance of an antibacterial can change over time.

The principal criteria used for the categorization are the indication and the availability of alternative antimicrobials for the treatment of infections in human medicine. The impact of antimicrobials used in veterinary medicine on human medicine are not considered, because this will be part of a separate risk assessment process, a human health risk assessment process.
The first criterion, the indication of a drug, includes the use of it in human medicine, the spectrum of activity and the effectiveness of the drug. A drug is more important if it is preferred for treatment of serious bacterial infections. Taking the second criterion, the availability of alternative antimicrobial drugs in account, there are also some groups of drugs more important than others. Drugs with limited or no alternatives for treatment, drugs where alternatives are within the same class, or drugs which are generally used as a last resort treatment, are considered to be more important. Acquired resistance, including multi-drug resistance, may make a drug ineffective and limit the availability of effective alternative antimicrobials. Table 1 shows the application of these criteria for antibacterial categorization (http://www.hc-sc.gc.ca (​http:​/​​/​www.hc-sc.gc.ca​)).

Table 1. The application of criteria for antibacterial categorization. (http://www.hc-sc.gc.ca (​http:​/​​/​www.hc-sc.gc.ca​))

Category 	Preferred option for treatment of serious human infections* 	No or limited alternatives available 
I – Very High Importance 	Yes 	Yes 
II – High Importance 	Yes 	No 
III – Medium Importance 	No 	No/Yes 
IV – Low Importance 	Not applicable 	Not applicable 

* Serious infections are those which, if left untreated, would lead to significant morbidity requiring emergency care (including hospitalization) and/or mortality.

The antibacterial drugs in category I are considered of very high importance in human medicine, because they are essential for the treatment of serious bacterial infections and have limited or no availability of alternative antimicrobials for effective treatment when they acquire resistance. Examples of category I drugs include:
-	Carbapenems 









-	Penicillin- β -lactamase inhibitor combinations 
-	Polymyxins (colistin) 
-	Streptogramins 
-	Therapeutic agents for tuberculosis (e.g., ethambutol, isoniazid, pyrazinamide and rifampin) 

The antibacterials in category II are those that can be used to treat different infections, including serious infections, and for which alternatives (most of the time category I drugs) are generally available. These antibacterials are considered of high importance in human medicine. Examples of category II drugs include:

-	Aminoglycosides (except topical agents)





-	Quinolones (except fluoroquinolones) 
-	Trimethoprim/sulfamethoxazole

The category III antibacterials are considered of medium importance in human medicine, they are used for treatment of bacterial infections for which alternatives are generally available. Bacteria resistant to drugs of this category are most of the time susceptible to category I or II antibacterials. Examples of category III drugs include:

-	Aminocyclitols 















The results in this report are based on data collected between February 2007 and December 2007. The quantity of antibiotics used on a farm has been converted to the quantity of active ingredient per cow per day (AI/cow/day). This number is multiplied by a thousand, to compare it on the same scale with the average number of cows on a farm. Looking at the scale of farm numbers, it seems that some numbers are missing, this is because of the fact that some farms dropped out of the project during its running.
The use of antibiotics and the possible influence of the number of cows on dairy farms in the different centres in Canada




Figure 2. The quantity of antibiotics used on the 17 farms in the Western centre compared to the average number of cows on each farm. 






Figure 3. The quantity of antibiotics used on the 22 farms in the Ontario centre compared to the average number of cows on each farm. 






Figure 4. The quantity of antibiotics used on the 28 farms in the Quebec centre compared to the average number of cows on each farm. 






Figure 5. The quantity of antibiotics used on the 17 farms in the Atlantic centre compared to the average number of cows on each farm. 

The use of antibiotics and the possible influence of the number of cows on dairy farms in Canada




Figure 6. The quantity of antibiotics used in the four centres in Canada compared to the average number of cows of the farms sampled in the centres. 

The use of different antimicrobial drug classes on dairy farms in the different centres in Canada
Figure 7 shows the use of the different antimicrobial drug classes on the farms in the Western centre. During the period of data collection, only one of the antimicrobial drug classes was administered on every farm, the penicillin combinations. Two different penicillin combinations were used in the Western centre. One of them was a combination of penicillin G, novobiocin, streptomycin and polymyxin B, the other one was a combination of penicillin G procaine and penicillin G benzathine.





Figure 7. The use of the different antimicrobial drug classes on the 17 farms sampled in the Western centre.


Figure 8 shows the use of the different antimicrobial drug classes on the farms in the Ontario centre. None of the farms administered, during the data collection period, antibiotics from all the antimicrobial drug classes shown in this figure. It is remarkable that two of the farms, farms numbers 204 and 216, did not use any penicillin during the collection period, they both used sulfonamides and tetracyclines in majority. Like the farms in the Western centre, the farms in the Ontario centre administered two different penicillin combinations: the penicillin G, novobiocin, streptomycin and polymyxin B combination, and the combination of penicillin G procaine and penicillin G benzathine. 





Figure 8. The use of the different antimicrobial drug classes on the 22 farms sampled in the Ontario centre.


Figure 9 shows the use of the different antimicrobial drug classes on the farms in the Quebec centre. In the period of data collection, only one of the antimicrobial drug classes was administered on every farm, the penicillins. The only penicillin combination administered on the farms in the Quebec centre is the penicillin G, novobiocin, streptomycin, and polymyxin B combination. 
Here follows a short enlightenment, because some classes are not clearly shown in figure 8. Sixteen of the 28 farms (farm numbers: 301-303, 305, 306, 309, 310, 313, 319, 323-327 and 329) used cephalosporins 1st generation. Macrolides were used in 14 of the 28 farms (farm numbers: 301, 304, 308, 310-314, 317, 319, 321, 323, 324 and 329). Twelve farms (farm numbers: 301, 302, 307, 310, 313, 316, 319, 320, 323-325 and 329) used lincosamides. Drugs belonging to the chloramphenicol group were only administered on three different farms (farm numbers: 308, 313 and 321). Only farm number 322 administered aminoglycosides. 





Figure 9. The use of the different antimicrobial drug classes on the 28 farms sampled in the Quebec centre.


Figure 10 shows the use of the different antimicrobial drug classes on the farms in the Atlantic centre. None of the farms administered, during the data collection period, antibiotics from all the antimicrobial drug classes shown in this figure. The only penicillin combination used on the farms in the Quebec centre was the penicillin G, novobiocin, streptomycin and polymyxin B combination. Only one farm, farm 411 did not administer any penicillin during the collection period, they almost exclusively administered macrolides.





Figure 10. The use of different antimicrobial drug classes on the 17 farms sampled in the Atlantic centre.

The use of different antimicrobial drug classes on dairy farms in Canada
Figure 11 shows the use of different antimicrobial drug classes in the four centres in Canada, more than 80% of the antibiotics administered in these centres consists of penicillins (combinations), sulfonamides and tetracyclines. Macrolides, cephalospirins 1st generation and lincosamides were administered in all four centres, although in smaller amounts. 




Figure 11. The use of different antimicrobial drug classes in the four centres in Canada.

The variety of products, belonging to the different antimicrobial drug classes, used in Canada




Figure 12. The variety of products, belonging to the different antimicrobial drug classes (x-scale), used in Canada.


The distribution of dairy barn types in the different centres in Canada




Figure 13. The distribution of barn types in the Western centre. The numbers along the pie-chart equals the number of farms in this centre.






Figure 14. The distribution of barn types in the Ontario centre. The numbers along the pie-chart equals the number of farms in this centre.





Figure 15. The distribution of barn types in the Quebec centre. The numbers along the pie-chart equals the number of farms in this centre.





Figure 16. The distribution of barn types in the Atlantic centre. The numbers along the pie-chart equals the number of farms in this centre.


The distribution of dairy barn types in Canada




Figure 17. The distribution of barn types in Canada. The numbers along the pie-chart equals the percentages of farms.

The possible influence of different dairy barn types on the use of antibiotics on dairy farms in Canada
Figure 18 shows the quantity of antibiotics used in the different barntypes in Canada. As written above, this information is based on 51 tie-stall barns, 28 free-stall barns and five bedding-pack barns. According to this, the bedding-pack barns used more antibiotics than the free-stall barns and tie-stall barns, and free-stall barns seemed to use a slightly larger quantity of antibiotics than tie-stall barns. 


Figure 18. The quantity of antibiotics used in the different barn types in Canada compared to the average number of cows of the farms sampled in the centres. 

Figure 18 also compares the average number of cows to the quantity of antibiotics used. Like figure 2-6, there seems to be no clear relationship between them, figure 18 does not show an obvious increasing use of antibiotics with an increasing or decreasing number of cows.
Importance in human medicine
Health Canada has tried to categorize antimicrobial drugs according to their importance in the treatment of serious bacterial infections, as written above. Antibacterial drugs belonging to the category I drugs are of very high importance in human medicine (http://www.hc-sc.gc.ca). In figure 19 it seems that category I drugs were used in Canada, according to the data this was enrofloxacin, belonging to the fluoroquinolones. It was administered once in a tie-stall barn in Quebec, with an average number of cows of 75.

Antibacterial drugs belonging to category II are of high importance in human medicine. It is, like category I drugs, a preferred option for treatment of serious human infections, but alternatives are available. This is in contrast with category I drugs, for which are no or limited alternatives available (http://www.hc-sc.gc.ca). More than 55% of the used quantity of antibiotics belongs to the category II drugs, as indicated by figure 19. According to the data, all four centres administered category II drugs. Penicillin belong to this category.
The majority of antibiotics used in Canada, belongs to the category III drugs, as shown in figure 19. They are of medium importance in human medicine, because they are not preferred for treatment of serious human infections, but they do not always have available alternatives (http://www.hc-sc.gc.ca). Category III antibiotics were used in all four centres. Sulfonamides and tetracyclines belong to this category.





Figure 19. The different categories of antibacterial drugs based on the importance in human medicine, used on the sampled farms in Canada. 

The use of antibiotics in Canada in comparison with the use of antibiotics in The Netherlands
Figure 20 shows the use of antimicrobial drug classes in Canada in comparison with the use of antimicrobial drug classes in The Netherlands. The information about the use of antimicrobial drug classes in The Netherlands is provided by the Dutch Maran report 2005 (Maran, 2005).
Interesting to see is that the dairy farms in Canada never used polymyxins in contrast to  The Netherlands. Farms in the Netherlands never used chlooramphenicol, because in this country it is forbidden to give it to food producing animals. Another remarkable point is the differences in percentages of the used antimicrobial drug classes between the two countries. Canada used in 2007 a higher percentage of penicillin than The Netherlands in 2005, about 50% versus 30% respectively. Almost 40% of the used antibiotics in The Netherlands belonged to the tetracyclines. Also the cephalosporins 1st generation is a more popular class than in Canada.
The two different penicillin combinations used in Canada consisted of penicillin G, novobiocin, streptomycin and polymyxin B, and of penicillin G procaine and penicillin G benzathine, as in the above. The Netherlands used three different penicillin combinations: amoxicillin-colistin, dihydrostreptomycin-benzylpenicillin, and neomycin-benzyl- penicillin (Maran, 2005).


Figure 20. The use of antimicrobial drug classes in Canada in comparison with the use of antimicrobial drug classes in The Netherlands.

Discussion
Selection of dairy producers
According to their bulk tank cell count, the herds are divided in three different BTSCC groups, based on the most recent 12-month period. These groups are, as in above, ≤ 150,000 cells/ml, > 150,000 cells/ml and ≤ 300,000 cells/ml, and > 300,000 cells/ml. The intention was to have in each group an equal number of selected herds. During the selection of the herds, it seemed very hard to get an equal number in each group. An unequal number of selected herds could have an influence on the use of antibiotics. 
Data collection
The list of the amount of cows per month on a farm, kept by the CBMRN itself, is not complete, not only does it miss the quantity of cows in February and March of 2007, it also misses the heifers and the calves. This list solely consists of the adult milking cows. Because the data collection has taken place over a long period and every AI/cow/day is based on the AI/adult milking cow/day, the comparison among the different farms should still be quite reliable. 
It has to be mentioned that the period of data collection differed from farm to farm. For example, on some farms data was collected for only two months, and on other farms this period was longer than seven months. Shorter sampling periods, which differ also in time of year, makes the comparison among the farms more vulnerable to influences of season and differences in the total number of cows on a farm over months.

This data collection took place in several areas in Canada. Because of the large distances among these areas, differences in climate should be taken into account. These differences could influence the use of antibiotics. 
The farmers are supposed to put all the used antibiotics in the garbage bin with: “all drugs” from the CBMRN project. It is possible that they or their employees forgot to do this. Some data-collectors of the CBMRN reported that some farmers did not understand this; these farmers have, for example, only thrown in the dry cow treatments.

It would be interesting to know the purposes of the used antibiotics. The CBMRN registers this on general health forms. The quantity of the antibiotics used on a farm and the intended use can be explained with this information. The results of the general health forms are, unfortunately, not yet available.
Methicillin-resistant Staphylococcus aureus
According to the results, dairy farms use a lot of penicillins (figure 11). The purposes of these penicillins are not yet known, because of the unavailable results of the general health forms. Even with the results of general health forms it could be hard to figure out if these penicillins were also used to treat an S. aureus infection, most of the farmers do not identify the causal agents of the infection before treatment.

According to Barkema et al. 2006, it is not only important to detect S. aureus early, but it is essential to treat only the cows with a reasonable probability of cure after treatment. The older the cow, the more infected quarters, the higher the SCC level before treatment, or the longer the duration of infection, the lower the chance of cure (Barkema et al., 2006).
Categorization of antimicrobial drugs based on importance in human medicine
Health Canada made this categorization by ranking the antibacterial drugs according to their chemical class. Because some of the drugs within the chemical class may not fall in the same category as the rest of the class, these exceptions should be treated on a case-by-case basis (http://www.hc-sc.gc.ca (​http:​/​​/​www.hc-sc.gc.ca​)). To categorize the used antibiotics collected in this project, it is essential to know in what case the antibiotic is administered, since this information is not available, exceptions are not treated on a case-by-case basis. Therefore, the categorization of the used antibiotics in this project is solely based on the chemical classes of these antibiotics.
Another point which is important to take into account is that the importance of an antibacterial to human medicine can change over time (http://www.hc-sc.gc.ca). The categorization of Health Canada dates from 2006, the possible changes over the years, whether available or not, have not been taken in to consideration in this project. 

At last, the impact of the use of antimicrobials in veterinary medicine on human medicine is not considered in this categorization, therefore it is not known what kind of consequences there are, using the different classes of antibiotics. How large is the impact when farmers use category II in majority? Are there already consequences when a farm used category I only once? Is it okay for human medicine that farms use class III antibiotics? These important questions are not yet answered. This report only shows what the selected farms have used last year.
The possible influence of the average number of cows on a farm or the type of barn on the use of antibiotics
According to the results of the average number of cows in comparison with the use of antibiotics, it is difficult to see a clear relationship between them. The results of the barn types in comparison with the use of antibiotics show an increased use of antibiotics in bedding-pack barns (figure 18), although this is based on only five bedding-pack barns, not enough to say a lot about it. According to the literature, there are more factors influencing the use of antibiotics, like the hygiene of the cows, the room to perform the actual process of standing and lying, the bedding in the stalls, the possible overcrowding, and the floor in the alleys of the barn.
A poor hygiene in dairy cows increases the risk of mastitis and lameness. There is more and more evidence that increased lying times have a beneficial effect on lameness prevalence and claw health. Less room to perform standing and lying down, a decrease in surface cushion in the stalls, and overcrowding have all found to decrease lying times in free-stalls. Rough walking surfaces have been related to an increase in lameness prevalence, and excessive exposure to concrete may result in excessive wear of the claws (Cook, 2002).
Conclusively, it is hard to find a clear relationship between the use of antibiotics and the amount of cows, and between the use of antibiotics and the barn types. More important factors are playing a role. 
The use of antibiotics in Canada in comparison with the use of antibiotics in the Netherlands
The comparison between Canada and the Netherlands, made in figure 20, has left some points of discussion. First of all, data of 2007 (Canada) is compared with data of 2005 (the Netherlands). The use of antibiotics in the Netherlands has changed over the years (Maran, 2005). A comparison of data both of 2007, may give a different view. Unfortunately, the last available Maran report is the one of 2005.

It is hard to explain the differences between both countries. So many influences can play a role, like the presence of an epidemic in that particular year, differences in climate etc. Because figure 20 shows the data in percentages, nothing can be said about the quantity of antibiotics used in both countries. The Maran report 2005 shows the data in daily dosages per cow per year (Maran, 2005). This is not comparable with the data in Canada, because the daily dosages can differ with those in the Netherlands, therefore it is hard to say anything about the larger percentage of fluoroquinolones, a class I drug in human medicine, used in the Netherlands (figure 20).
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Appendix: Dairy Medications GCA Tally Sheet: these sheets are used to write down the amount of antibiotics on a farm, found in the garbage bin of the CBMRN.
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